During the past decade, Chiinkai Dojima General & Gastroenterology Clinic conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Chiinkai Dojima General & Gastroenterology Clinic" are "Crohn's Disease" (3 trials) and "Ulcerative Colitis" (3 trials). Many other conditions were trialed in "Chiinkai Dojima General & Gastroenterology Clinic" in a lesser frequency.

Most popular intervention types in "Chiinkai Dojima General & Gastroenterology Clinic" are "Drug" (4 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ontamalimab" (4 trials), "Placebo" (4 trials), "25 mg Ontamalimab" (1 trials) and "75 mg Ontamalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chiinkai Dojima General & Gastroenterology Clinic" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Chiinkai Dojima General & Gastroenterology Clinic". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Chiinkai Dojima General & Gastroenterology Clinic, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Chiinkai Dojima General & Gastroenterology Clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".